Answer
Regadenoson lacks adequate pregnancy data in humans; animal studies showed fetotoxicity but not teratogenicity, pre- and post-natal development studies were not conducted, human risk is unknown, and use during pregnancy is advised only if clearly necessary.
Sources for this answer
- Rapiscan 400 microgram solution for injectionGE Healthcare Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked